Pink Sheet editors say FDA reviewers warn the peptides lack clinical testing, and some career staff may quit if the order goes ahead.
Recap by typeshit. Full story at BigGo Finance.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
Novo also presented liver fat data from STEP-UP and an Ozempic vs Mounjaro heart risk analysis, and paid $300 million upfront for Hengrui's HRS-1596.
19:56
A performance coach shares his own checklist for people beginning retatrutide, the Lilly drug that is still in trials and not approved.
Loading…